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Radiation-induced skin injury ranges from acute
dermatitis to chronic skin changes.1,2 Acute skin injury
occurs during the course of radiation treatment and
may take 1 to 3 months after the completion of radiation
therapy to completely heal. Patients with mild
acute dermatitis present with mild erythema, dry
desquamation, pruritus, hyperpigmentation, and hair
loss. Severe acute dermatitis is characterized by
conﬂuent moist desquamation, ulcers, hemorrhage, and
necrosis.1,3 Chronic radiation-induced skin injury in-
cludes chronic ﬁbrosis with associated skin breakdown
and infection.1,4
The severity of radiation-induced skin toxicity depends
on radiation factors (dose, fractionation, volume, and
surface area) and patient-speciﬁc factors. Excessive
skinfolds increase radiation-induced skin toxicity. Also,
patients with poor nutrition status or a preexisting
vascular condition or connective tissue disease have
impaired wound healing and are at increased risk of skin
toxicity.5 Actinic lichen planus is an autoimmune skin
disease characterized by a violaceous papule rash.6 Here,
we report the case of a patient with presumed latent
actinic lichen planus treated with deﬁnitive radiation
therapy who subsequently developed overt lichen planus
and severe radiation dermatitis in the treatment ﬁelds.Conﬂicts of interest: None.
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A 55-year-old African American woman presented
with intermittent hoarseness over several years, eventually
limiting her voice to a whisper. She denied dysphagia,
odynophagia, otalgia, dyspnea, or stridor. Suspension
microlaryngoscopy revealed a bulky left vocal cord
lesion. Bilateral vocal fold biopsies were obtained,
and pathology revealed a superﬁcially invasive, well-
differentiated squamous cell carcinoma of the left true
vocal cord without invasion of the right true vocal cord.
She was staged as cT1bN0M0.
The patient was treated with deﬁnitive radiation ther-
apy to the larynx and received a total dose of 62 Gy in 31
fractions of 2 Gy each delivered once daily using 6-MV
photons, per our departmental policy. The total treatment
duration was 50 days, including breaks and weekends.
After she received 14 Gy, she had a treatment break of 10
days because she was hospitalized at an outside facility
for a gastrointestinal bleed. She then completed treatment
as planned. Right and left posterior oblique ﬁelds were
used, with gantry angles of 260 and 100, respectively.
Thirty-degree wedges were used to reduce anterior hot-
spots. The ﬁeld sizes were 5.7 cm superior to inferior and
4.6 cm anterior to posterior. No bolus was used
throughout the course of radiation therapy. The dosimetry
is shown in Fig 1.
During treatment she experienced grade 3 radiation
dermatitis, grade 1 hoarseness, and grade 2 pharyngeal
mucositis. Table 1 lists the toxicity grades for radiation
dermatitis. Her skin toxicity became most severe after
receiving 52 Gy. The radiation plan was reviewed, and
optically stimulated luminescent dosimeters were used toof the American Society for Radiation Oncology. This is an open access
by-nc-nd/4.0/).
Figure 1 Dosimetry. (A) Representative axial sections showing isodose lines. Green Z 62 Gy, cyan Z 50 Gy, orange Z 30 Gy.
(B) Three-dimensional rendering of isodose lines. Mandible is purple, spinal cord is light orange, and brain stem is yellow.
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fraction. She was prescribed silver sulfadiazine 1% for
management of her dermatitis and hydrocodone with
acetaminophen 7.5 to 500 mg/15 mL oral solution for
pain control; however, the radiation dermatitis persisted
through the end of treatment. On her ﬁnal day of treat-
ment, she had developed skin hyperpigmentation in the
anterior neck, including the superior border of nodal
station 2 through the inferior border of nodal station 3.
She developed moist desquamation in the areas where the
oblique ﬁelds entered through the skin, correlating with
the 50-Gy isodose line. Our patient’s dermatitis healed
after 2 months, as depicted in Fig 2.
One month after our patient completed radiation ther-
apy, she presented to dermatology and was noted to have
gray to violaceous patches in the buccal mucosa and
tongue. She also had many scattered ﬂat-topped hyper-
pigmented to violaceous patches in the extremities andTable 1 Toxicity grades for radiation dermatitis, deﬁned as
a ﬁnding of cutaneous inﬂammatory reaction occurring as a
result of exposure to biologically effective levels of ionizing
radiation
Radiation
dermatitis
grade
1 Faint erythema or dry desquamation
2 Moderate to brisk erythema; patchy moist
desquamation, mostly conﬁned to skin folds
and creases; moderate edema
3 Moist desquamation in areas other than skin
folds and creases; bleeding induced by minor
trauma or abrasion
4 Life-threatening consequences; skin necrosis or
ulceration of full thickness dermis; spontaneous
bleeding from involved site; skin graft indicated
5 Death
Adapted from Common Terminology Criteria for Adverse Events
(CTCAE) version 4.03, June 14, 2010, U.S. Department of Health
and Human Services.buttocks. She reported an intermittent pruritic rash of the
arms, legs, and trunk for the previous 10 years. She was
using triamcinolone cream and hydroxyzine with minimal
improvement in this rash. A shave biopsy was obtained
from a representative lesion in the right volar forearm.
Pathology showed patchy interface dermatitis with pigment
incontinence, compact orthokeratosis with hyper-
granulosis, focal basal layer squamatization, and occasional
apoptotic keratinocytes limited to the lower portion of the
epidermis. Based on the clinical and histological ﬁndings,
she was diagnosed with actinic lichen planus.Discussion
Actinic lichen planus is an inﬂammatory skin reaction
thought to be caused by an autoimmune reaction that
typically develops on sun-exposed areas in dark-skinned
individuals. Only 7 cases of radiation-induced cutaneous
lichen planus have been reported, shown in Table 2.7-13
However, no report to our knowledge discusses
radiation-induced skin toxicity in a patient with lichen
planus. The case presented here is the ﬁrst case of severe
radiation dermatitis in the treatment ﬁeld of a patient with
presumed occult actinic lichen planus.
At our institution, T1 glottis squamous cell carcinomas
are treated with doses of 60 to 66 Gy in fractions of 2 Gy,
with a local control exceeding 90% (unpublished data).
The generally accepted radiation treatment for T1 glottic
cancers is a hypofractionated course of 63 Gy in 2.25 Gy
per fraction based on the study by Yamazaki et al that
showed improved local control in the hypofractionation
arm versus the conventional fractionation arm (60-66 Gy
in 2 Gy per fraction).14 However, in the aforementioned
study, local control in the conventional fractionation arm
was only 77% at 5 years.14 Previous studies have shown
the 5-year local control of T1 squamous cell carcinomas
of the glottis treated with conventional fractionation to be
88%15; therefore, we have adopted a conventional frac-
tionation treatment regimen in the management of T1
squamous cell carcinomas of the glottis.
Figure 2 Grade 3 radiation dermatitis. (A) Before radiation treatment. (B) On the ﬁnal day of radiation treatment. (C) Three weeks
after radiation treatment. (D) Two months after radiation treatment.
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for laryngeal cancer include hoarseness, sore throat,
odynophagia, and skin irritation. A concerning late
toxicity is laryngeal edema.16 Regarding skin toxicity,
Emami et al showed that, when a 30 cm2 area of skin
receives a dose of 60 Gy or a 10 cm2 area of skin re-
ceives a dose of 70 Gy, there is a 5% risk of developingTable 2 Case reports of postradiation cutaneous lichen
planus
Author Year Site Localized/diffuse
actinic lichen
planus
Boyd et al7 1991 Breast Diffuse
Eichbaum et al8 2006 Breast Diffuse
Morar et al10 2009 Plasmacytoma
of skull
Diffuse
Kim et al9 2002 Thyroid Localized
Shurman et al12 2004 Penis Localized
Vergilis-Kalner
et al13
2008 Metastatic
breast and
thigh
Localized
Pretel et al11 2007 Breast Localizednecrosis and ulceration within 5 years from radiation
therapy.17 In the presenting case, each treatment ﬁeld
was 26.2 cm2, and the maximum point dose was 69.5
Gy. Additionally, our patient developed grade 3 derma-
titis after receiving 52 Gy and with an unexpected
10-day treatment break after 7 fractions. In the Yamazaki
et al hypofractionation study, only 9% of patients in the
hypofractionation arm developed dry desquamation, and
no patient in that study developed moist desquamation.14
Thus, given the treatment factors for our patient, grade 3
radiation dermatitis is well beyond the realm of expected
toxicities. Our patient had symptoms of lichen planus
before radiation therapy to the larynx; however, at the
time of treatment, she had not yet been diagnosed with
actinic lichen planus. Our report represents the ﬁrst case
of a patient with occult actinic lichen planus to develop
grade 3 radiation-induced dermatitis in the treatment
ﬁeld following external beam radiation therapy for
squamous cell carcinoma of the vocal cord. Although
previous case reports showed that radiation therapy may
induce or exacerbate localized or diffuse lichen planus,
we show that the severity of radiation dermatitis was
increased in an irradiated patient with presumed latent
actinic lichen planus.
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We present a case in which radiation dermatitis was
worsened in a patient with presumed latent actinic lichen
planus. In addition to discussing possible increased risks
of radiation toxicity in patients with collagen vascular
disease, our case indicates that patients with lichen planus
should also be informed of possible increased risks of
radiation toxicity. It is uncertain how to properly treat
lichen planus patients requiring external radiation for
malignancies. With an understanding of the inﬂammatory
mechanisms and factors in lichen planus patients
following external beam radiation therapy, we can better
manage these patients and limit radiation toxicity.
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